PGP and breast cancer: To test whether CLDN6 affects chemoresistance in breast cancer cells, we utilized RNAi to transiently (Fig. 1c) or stalely (Fig. 1d) inhibit CLDN6 expression in MCF-7/MDR cells and we found that expression of P-gp also decreased simultaneously.